Skip to content
DataLookout
Menu

Chengdu Suncadia Medicine Co., Ltd. clinical trial pipeline

Get alerts when Chengdu Suncadia Medicine Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor: HRS-5965 Capsule in Primary IgA Nephropathy Enrollment closed, study ongoing Chengdu Suncadia Medicine Co., Ltd.Phase 3 NCT07014826
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-11-16 NCT07940166 A Study of HRS-8046 in Patients With Advanced Solid Tumors: Safety, Tolerability, and… Phase 1 Not Yet Recruiting
2026-11-16 NCT07940439 A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-9308… Phase 1/2 Not Yet Recruiting

Active trials by phase

Phase 1
4
Phase 1/2
1
Phase 2
3
Phase 3
1

Disease areas by active trials

Get alerts when Chengdu Suncadia Medicine Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free